$TRNS
TRANSCAT INC Stock $trns

$trns Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-Q Financial Statement

#000143774923021645 Filed on August 02, 2023

Income Statement

Concept	2023 Q3	2023 Q2	2022 Q2
Revenue	$62.80M	$60.60M	$54.66M
YoY Change	11.28%	10.86%	14.38%
Cost Of Revenue	$42.68M	$41.89M	$38.62M
YoY Change	7.58%	8.45%	12.7%
Gross Profit	$20.13M	$18.71M	$16.04M
YoY Change	20.03%	16.66%	18.62%
Gross Profit Margin	32.04%	30.88%	29.34%
Selling, General & Admin	$18.48M	$13.89M	$12.43M
YoY Change	40.64%	11.67%	26.48%
% of Gross Profit	91.84%	74.21%	77.53%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$3.290M	$2.790M	$2.641M
YoY Change	18.43%	5.64%	32.71%
% of Gross Profit	16.35%	14.91%	16.47%
Operating Expenses	$18.48M	$13.89M	$12.43M
YoY Change	40.64%	11.67%	26.48%
Operating Profit	$1.643M	$4.825M	$3.604M
YoY Change	-54.69%	33.88%	-2.3%
Interest Expense	-$890.0K	-$814.0K	-$360.0K
YoY Change	61.82%	126.11%	90.48%
% of Operating Profit	-54.17%	-16.87%	-9.99%
Other Income/Expense, Net	-$841.0K	-$64.00K	-$156.0K
YoY Change	56.61%	-58.97%	-20.0%
Pretax Income	$802.0K	$3.762M	$3.448M
YoY Change	-74.04%	9.11%	-1.32%
Income Tax	$342.0K	$813.0K	$376.0K
% Of Pretax Income	42.64%	21.61%	10.9%
Net Earnings	$460.0K	$2.949M	$3.072M
YoY Change	-80.48%	-4.0%	-16.7%
Net Earnings / Revenue	0.73%	4.87%	5.62%
Basic Earnings Per Share	$0.06	$0.39	$0.41
Diluted Earnings Per Share	$0.06	$0.38	$0.40
COMMON SHARES
Basic Shares Outstanding	7.688M	7.643M	7.535K shares
Diluted Shares Outstanding	7.948M	7.762M	7.629K shares

Balance Sheet

Concept	2023 Q3	2023 Q2	2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.200M	$2.149M	$443.0K
YoY Change	32.01%	385.1%	74.41%
Cash & Equivalents	$1.246M	$2.149M	$443.0K
Short-Term Investments
Other Short-Term Assets	$3.500M	$3.393M	$4.853M
YoY Change	-20.8%	-30.08%	54.6%
Inventory	$15.69M	$15.18M	$14.94M
Prepaid Expenses
Receivables	$44.38M	$42.36M	$38.03M
Other Receivables	$335.0K	$527.0K	$533.0K
Total Short-Term Assets	$65.17M	$63.60M	$58.80M
YoY Change	4.08%	8.17%	20.63%
LONG-TERM ASSETS
Property, Plant & Equipment	$35.65M	$46.47M	$27.19M
YoY Change	28.37%	70.92%	22.61%
Goodwill	$106.4M	$77.05M	$66.65M
YoY Change	60.87%	15.61%	51.8%
Intangibles	$23.16M	$15.14M	$16.04M
YoY Change	55.62%	-5.56%	132.37%
Long-Term Investments
YoY Change
Other Assets	$1.083M	$1.066M	$830.0K
YoY Change	34.53%	28.43%	-13.18%
Total Long-Term Assets	$183.0M	$139.7M	$123.2M
YoY Change	47.49%	13.38%	49.57%
TOTAL ASSETS
Total Short-Term Assets	$65.17M	$63.60M	$58.80M
Total Long-Term Assets	$183.0M	$139.7M	$123.2M
Total Assets	$248.2M	$203.3M	$182.0M
YoY Change	32.93%	11.7%	38.81%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$12.52M	$11.56M	$12.97M
YoY Change	-7.91%	-10.82%	15.75%
Accrued Expenses	$11.50M	$9.290M	$8.584M
YoY Change	26.57%	8.22%	17.4%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$2.293M	$2.270M	$2.183M
YoY Change	3.99%	3.99%	4.5%
Total Short-Term Liabilities	$28.11M	$23.73M	$23.73M
YoY Change	12.94%	-0.04%	15.19%
LONG-TERM LIABILITIES
Long-Term Debt	$51.00M	$46.09M	$49.60M
YoY Change	4.92%	-7.07%	146.66%
Other Long-Term Liabilities	$5.477M	$15.61M	$1.650M
YoY Change	267.09%	846.06%	-49.43%
Total Long-Term Liabilities	$56.48M	$61.70M	$51.25M
YoY Change	12.73%	20.4%	119.28%
TOTAL LIABILITIES
Total Short-Term Liabilities	$28.11M	$23.73M	$23.73M
Total Long-Term Liabilities	$56.48M	$61.70M	$51.25M
Total Liabilities	$110.0M	$92.61M	$92.49M
YoY Change	16.49%	0.13%	69.91%
SHAREHOLDERS EQUITY
Retained Earnings	$71.02M	$71.90M	$61.55M
YoY Change	11.13%	16.82%	14.8%
Common Stock	$68.30M	$39.54M	$28.69M
YoY Change	128.05%	37.8%	22.79%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$138.3M	$110.7M	$89.55M
YoY Change
Total Liabilities & Shareholders Equity	$248.2M	$203.3M	$182.0M
YoY Change	32.93%	11.7%	38.81%

Cashflow Statement

Concept	2023 Q3	2023 Q2	2022 Q2
OPERATING ACTIVITIES
Net Income	$460.0K	$2.949M	$3.072M
YoY Change	-80.48%	-4.0%	-16.7%
Depreciation, Depletion And Amortization	$3.290M	$2.790M	$2.641M
YoY Change	18.43%	5.64%	32.71%
Cash From Operating Activities	$8.430M	$7.536M	$2.043M
YoY Change	164.1%	268.87%	-0.58%
INVESTING ACTIVITIES
Capital Expenditures	$2.670M	$2.767M	$2.399M
YoY Change	-212.52%	15.34%	99.42%
Acquisitions		$2.869M	$4.040M
YoY Change		-28.99%	333.94%
Other Investing Activities	-$10.01M	-$2.869M	-$4.030M
YoY Change		-28.81%	332.87%
Cash From Investing Activities	-$12.69M	-$5.636M	-$6.429M
YoY Change	434.77%	-12.33%	201.27%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$216.0K
YoY Change			-91.93%
Debt Paid & Issued, Net		$553.0K	$490.0K
YoY Change		12.86%	-19.41%
Cash From Financing Activities	3.170M	-859.0K	$3.110M
YoY Change	-485.64%	-127.62%	-7332.56%
NET CHANGE
Cash From Operating Activities	8.430M	7.536M	$2.043M
Cash From Investing Activities	-12.69M	-5.636M	-$6.429M
Cash From Financing Activities	3.170M	-859.0K	$3.110M
Net Change In Cash	-1.090M	1.041M	-$953.0K
YoY Change	36233.33%	-209.23%	211.44%
FREE CASH FLOW
Cash From Operating Activities	$8.430M	$7.536M	$2.043M
Capital Expenditures	$2.670M	$2.767M	$2.399M
Free Cash Flow	$5.760M	$4.769M	-$356.0K
YoY Change	3.5%	-1439.61%	-141.78%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q2	dei	Amendment Flag AmendmentFlag	false
CY2023Q2	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--03-25
CY2023Q2	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q2	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	2000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	-4000	usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	515000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	457000	usd
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.50
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.50
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	30000000
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	30000000
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	7643099
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	7643099
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	7562604
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	7562604
CY2023Q1	us-gaap	Investments Investments	200000	usd
CY2022Q2	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	100000	usd
CY2022Q2	trns	Dilutive Securities Effect Per Share On Earnings DilutiveSecuritiesEffectPerShareOnEarnings	0.01
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	200000	usd
CY2022Q2	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	100000	usd
CY2022Q2	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	0	usd
CY2023Q2	dei	Document Type DocumentType	10-Q
CY2023Q2	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q2	dei	Document Period End Date DocumentPeriodEndDate	2023-06-24
CY2023Q2	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q2	dei	Entity File Number EntityFileNumber	000-03905
CY2023Q2	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	OH
CY2023Q2	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	16-0874418
CY2023Q2	dei	Entity Address Address Line1 EntityAddressAddressLine1	35 Vantage Point Drive
CY2023Q2	dei	Entity Address City Or Town EntityAddressCityOrTown	Rochester
CY2023Q2	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2023Q2	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	14624
CY2023Q2	dei	City Area Code CityAreaCode	585
CY2023Q2	dei	Local Phone Number LocalPhoneNumber	352-7777
CY2023Q2	dei	Security12b Title Security12bTitle	Common Stock, $0.50 par value
CY2023Q2	dei	Trading Symbol TradingSymbol	TRNS
CY2023Q2	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023Q2	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q2	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q2	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2023Q2	dei	Entity Small Business EntitySmallBusiness	false
CY2023Q2	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q2	dei	Entity Shell Company EntityShellCompany	false
CY2023Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	7687851
CY2023Q2	us-gaap	Revenues Revenues	60598000	usd
CY2022Q2	us-gaap	Revenues Revenues	54661000	usd
CY2023Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	41888000	usd
CY2022Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	38623000	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	18710000	usd
CY2022Q2	us-gaap	Gross Profit GrossProfit	16038000	usd
CY2023Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	6469000	usd
CY2022Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	5820000	usd
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7601000	usd
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6614000	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	14070000	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	12434000	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	4640000	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	3604000	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-878000	usd
CY2022Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-156000	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	3762000	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	3448000	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	813000	usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	376000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	2949000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	3072000	usd
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.39
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.41
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7622000
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7535000
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.38
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.40
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7762000
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7629000
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	2949000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	3072000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	476000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-440000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	6000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-13000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	482000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-453000	usd
CY2023Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	3431000	usd
CY2022Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	2619000	usd
CY2023Q2	us-gaap	Cash Cash	2149000	usd
CY2023Q1	us-gaap	Cash Cash	1531000	usd
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	42356000	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	44698000	usd
CY2023Q2	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	527000	usd
CY2023Q1	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	506000	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	15177000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	16929000	usd
CY2023Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3393000	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3935000	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	63602000	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	67599000	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	30186000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	29064000	usd
CY2023Q2	us-gaap	Goodwill Goodwill	77051000	usd
CY2023Q1	us-gaap	Goodwill Goodwill	69360000	usd
CY2023Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	15144000	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	13799000	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	16280000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	14876000	usd
CY2023Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1066000	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1051000	usd
CY2023Q2	us-gaap	Assets Assets	203329000	usd
CY2023Q1	us-gaap	Assets Assets	195749000	usd
CY2023Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	11564000	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	15869000	usd
CY2023Q2	trns	Accrued Compensation And Other Liabilities Current AccruedCompensationAndOtherLiabilitiesCurrent	9290000	usd
CY2023Q1	trns	Accrued Compensation And Other Liabilities Current AccruedCompensationAndOtherLiabilitiesCurrent	10201000	usd
CY2023Q2	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	601000	usd
CY2023Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	0	usd
CY2023Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	2270000	usd
CY2023Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	2248000	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	23725000	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	28318000	usd
CY2023Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	46090000	usd
CY2023Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	46869000	usd
CY2023Q2	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	7184000	usd
CY2023Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	6538000	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	14170000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	12960000	usd
CY2023Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1440000	usd
CY2023Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1434000	usd
CY2023Q2	us-gaap	Liabilities Liabilities	92609000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	96119000	usd
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	3822000	usd
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	3781000	usd
CY2023Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	35717000	usd
CY2023Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	27886000	usd
CY2023Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-718000	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1200000	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	71899000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	69163000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	110720000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	99630000	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	203329000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	195749000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	2949000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	3072000	usd
CY2023Q2	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-8000	usd
CY2022Q2	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-10000	usd
CY2023Q2	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	44000	usd
CY2022Q2	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-23000	usd
CY2023Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2790000	usd
CY2022Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2641000	usd
CY2023Q2	trns	Accounts Receivable Credit Loss Expense Reversal And Inventory Writedown AccountsReceivableCreditLossExpenseReversalAndInventoryWritedown	138000	usd
CY2022Q2	trns	Accounts Receivable Credit Loss Expense Reversal And Inventory Writedown AccountsReceivableCreditLossExpenseReversalAndInventoryWritedown	88000	usd
CY2023Q2	us-gaap	Share Based Compensation ShareBasedCompensation	930000	usd
CY2022Q2	us-gaap	Share Based Compensation ShareBasedCompensation	828000	usd
CY2023Q2	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	-3115000	usd
CY2022Q2	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	-1578000	usd
CY2023Q2	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-1950000	usd
CY2022Q2	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2118000	usd
CY2023Q2	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-531000	usd
CY2022Q2	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-432000	usd
CY2023Q2	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-4315000	usd
CY2022Q2	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1218000	usd
CY2023Q2	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-1203000	usd
CY2022Q2	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-3247000	usd
CY2023Q2	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	599000	usd
CY2022Q2	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	0	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	7536000	usd
CY2022Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2043000	usd
CY2023Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2767000	usd
CY2022Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2399000	usd
CY2023Q2	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	usd
CY2022Q2	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	10000	usd
CY2023Q2	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	2869000	usd
CY2022Q2	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	4040000	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-5636000	usd
CY2022Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-6429000	usd
CY2023Q2	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	-204000	usd
CY2022Q2	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	3816000	usd
CY2023Q2	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	553000	usd
CY2022Q2	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	490000	usd
CY2023Q2	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	199000	usd
CY2022Q2	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	221000	usd
CY2023Q2	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	301000	usd
CY2022Q2	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	437000	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-859000	usd
CY2022Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3110000	usd
CY2023Q2	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-423000	usd
CY2022Q2	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	323000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	618000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-953000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1531000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1396000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2149000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	443000	usd
CY2023Q2	us-gaap	Interest Paid Net InterestPaidNet	816000	usd
CY2022Q2	us-gaap	Interest Paid Net InterestPaidNet	322000	usd
CY2023Q2	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	107000	usd
CY2022Q2	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	117000	usd
CY2023Q2	us-gaap	Stock Issued1 StockIssued1	6831000	usd
CY2022Q2	us-gaap	Stock Issued1 StockIssued1	145000	usd
CY2023Q2	trns	Noncash Or Part Noncash Acquisition Accrued Contingent Consideration Related To Acquisition NoncashOrPartNoncashAcquisitionAccruedContingentConsiderationRelatedToAcquisition	0	usd
CY2022Q2	trns	Noncash Or Part Noncash Acquisition Accrued Contingent Consideration Related To Acquisition NoncashOrPartNoncashAcquisitionAccruedContingentConsiderationRelatedToAcquisition	518000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	86176000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	366000	usd
CY2022Q2	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	437000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	828000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Other Net Of Tax OtherComprehensiveIncomeOtherNetOfTax	-453000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	3072000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	89552000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	99630000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	7030000	usd
CY2023Q2	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	301000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	930000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Other Net Of Tax OtherComprehensiveIncomeOtherNetOfTax	482000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	2949000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	110720000	usd
CY2023Q2	us-gaap	Investments Investments	200000	usd
CY2023Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	900000	usd
CY2022Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	800000	usd
CY2023Q2	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	100000	usd
CY2022Q2	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	200000	usd
CY2023Q2	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	100000	usd
CY2023Q2	trns	Dilutive Securities Effect Per Share On Earnings DilutiveSecuritiesEffectPerShareOnEarnings	0.01
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7622000
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7535000
CY2023Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	140000
CY2022Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	94000
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7762000
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7629000
CY2023Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	57000
CY2022Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	145000
CY2023Q1	us-gaap	Goodwill Goodwill	69360000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	13799000	usd
CY2023Q2	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	7438000	usd
CY2023Q2	us-gaap	Finitelived Intangible Assets Acquired1 FinitelivedIntangibleAssetsAcquired1	2435000	usd
CY2023Q2	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	-0	usd
CY2023Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1093000	usd
CY2023Q2	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	253000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Foreign Currency Translation Gain Loss FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss	3000	usd
CY2023Q2	us-gaap	Goodwill Goodwill	77051000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	15144000	usd
CY2023Q2	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	100000	usd
CY2022Q2	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	500000	usd
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	217000
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	56.25
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	16000
CY2023Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	83.59
CY2023Q2	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	3000
CY2023Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	24.30
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	2000
CY2023Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	63.17
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	228000
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	58.45
CY2023Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	6579000	usd
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	42000
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	49.59
CY2023Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P6Y
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	1563000	usd
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	200000	usd
CY2023Q2	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	100000	usd
CY2023Q2	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	pure
CY2023Q2	us-gaap	Revenues Revenues	60598000	usd
CY2022Q2	us-gaap	Revenues Revenues	54661000	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	18710000	usd
CY2022Q2	us-gaap	Gross Profit GrossProfit	16038000	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	14070000	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	12434000	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	4640000	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	3604000	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-878000	usd
CY2022Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-156000	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	813000	usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	376000	usd
CY2023Q2	us-gaap	Other General Expense OtherGeneralExpense	1691000	usd
CY2022Q2	us-gaap	Other General Expense OtherGeneralExpense	532000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	2949000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	3072000	usd
CY2023Q2	us-gaap	Revenues Revenues	60598000	usd
CY2022Q2	us-gaap	Revenues Revenues	54661000	usd
CY2023Q2	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	60598000	usd
CY2022Q2	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	56829000	usd
CY2023Q2	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	2964000	usd
CY2022Q2	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	3270000	usd
CY2023Q2	us-gaap	Business Acquisition Pro Forma Earnings Per Share Basic BusinessAcquisitionProFormaEarningsPerShareBasic	0.39
CY2022Q2	us-gaap	Business Acquisition Pro Forma Earnings Per Share Basic BusinessAcquisitionProFormaEarningsPerShareBasic	0.43
CY2023Q2	us-gaap	Business Acquisition Pro Forma Earnings Per Share Diluted BusinessAcquisitionProFormaEarningsPerShareDiluted	0.38
CY2022Q2	us-gaap	Business Acquisition Pro Forma Earnings Per Share Diluted BusinessAcquisitionProFormaEarningsPerShareDiluted	0.43
CY2023Q2	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	0	usd
CY2023Q2	trns	Unpaid Amounts For Other Holdbacks UnpaidAmountsForOtherHoldbacks	100000	usd
CY2023Q2	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	0	usd
CY2023Q2	trns	Payments For Other Holdbacks PaymentsForOtherHoldbacks	300000	usd
CY2022Q2	trns	Payments For Other Holdbacks PaymentsForOtherHoldbacks	0	usd

Files In Submission

Name	View Source	Status
0001437749-23-021645-index-headers.html	Edgar Link	pending
0001437749-23-021645-index.html	Edgar Link	pending
0001437749-23-021645.txt	Edgar Link	pending
0001437749-23-021645-xbrl.zip	Edgar Link	pending
ex_538809.htm	Edgar Link	pending
ex_538810.htm	Edgar Link	pending
ex_538811.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
trns-20230624.xsd	Edgar Link	pending
trns20230627_10q.htm	Edgar Link	pending
trns-20230624_def.xml	Edgar Link	unprocessable
trns-20230624_lab.xml	Edgar Link	unprocessable
trns-20230624_pre.xml	Edgar Link	unprocessable
trns20230627_10q_htm.xml	Edgar Link	completed
FilingSummary.xml	Edgar Link	unprocessable
trns-20230624_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$TRNS
TRANSCAT INC Stock $trns

2023 Q3 Form 10-Q Financial Statement

#000143774923021645 Filed on August 02, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TRNS TRANSCAT INC Stock $trns

2023 Q3 Form 10-Q Financial Statement

#000143774923021645 Filed on August 02, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TRNS
TRANSCAT INC Stock $trns